Montana § 33-2-2410 Federal 340b Drug Pricing Program

Montana Statutes

§ 33-2-2410 — Federal 340b Drug Pricing Program

Montana § 33-2-2410

Title 33INSURANCE AND INSURANCE COMPANIES

Ch. 2REGULATION OF INSURANCE COMPANIES

Part 24Pharmacy Benefit Manager Oversight

This text of Montana § 33-2-2410 (Federal 340b Drug Pricing Program) is published on Counsel Stack Legal Research, covering Montana primary law. Counsel Stack provides free access to over 12 million legal documents including statutes, case law, regulations, and constitutions.

Bluebook

Mont. Code Ann. § 33-2-2410 (2026).

Text

33-2-2410 . Federal 340B drug pricing program. A pharmacy benefit manager or health carrier may not:

(1)prohibit a federally certified health entity or a pharmacy under contract with an entity to provide pharmacy services from participating in the pharmacy benefit manager's or health carrier's provider network;

(2)reimburse a federally certified health entity or a pharmacy under contract with an entity differently than it reimburses other similarly situated pharmacies;

(3)require a claim for a drug to include a modifier to indicate that the drug is a 340B drug unless the claim is for payment, directly or indirectly, by the medicaid program provided for in Title 53, chapter 6, part 1; or

(4)create a restriction or an additional charge on a patient who chooses to receive drugs from a fed

Free access — add to your briefcase to read the full text and ask questions with AI

33-2-2410 . Federal 340B drug pricing program. A pharmacy benefit manager or health carrier may not:
(1) prohibit a federally certified health entity or a pharmacy under contract with an entity to provide pharmacy services from participating in the pharmacy benefit manager's or health carrier's provider network;
(2) reimburse a federally certified health entity or a pharmacy under contract with an entity differently than it reimburses other similarly situated pharmacies;
(3) require a claim for a drug to include a modifier to indicate that the drug is a 340B drug unless the claim is for payment, directly or indirectly, by the medicaid program provided for in Title 53, chapter 6, part 1; or
(4) create a restriction or an additional charge on a patient who chooses to receive drugs from a federally certified health entity or a pharmacy under contract with an entity, including but not limited to a patient's inability to fully pay a copayment. (Subsection (3) terminates June 1, 2029--sec. 34, Ch. 8, L. 2025.)